Cargando…
Prospective, randomised, multicentre, open-label trial, designed to evaluate the best timing of closure of the temporary ileostomy (early versus late) in patients who underwent rectal cancer resection and with indication for adjuvant chemotherapy: the STOMAD (STOMa closure before or after ADjuvant therapy) randomised controlled trial
INTRODUCTION: Temporary ileostomy is a valuable aid in reducing the severity of complications related to rectal cancer surgery. However, it is still unclear what is the best timing of its closure in relation to the feasibility of an adjuvant treatment, especially considering patient-reported outcome...
Ejemplares similares
-
Skin and subcutaneous fascia closure at caesarean section to reduce wound complications: the closure randomised trial
por: Poprzeczny, Amanda J., et al.
Publicado: (2020) -
Robotic transanal total mesorectal excision: A new perspective for low rectal cancer treatment. A case series
por: Monsellato, Igor, et al.
Publicado: (2019) -
Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy
por: Boutros, Cherif, et al.
Publicado: (2010) -
Comparison between open and open-vacuum-assisted closure treatment in the adjuvant treatment of the abdominal compartment syndrome
por: Nella, A, et al.
Publicado: (2009) -
Clinical Outcomes of Ileostomy Closure According to Timing During Adjuvant Chemotherapy After Rectal Cancer Surgery
por: Choi, Yoo Jin, et al.
Publicado: (2019)